The groundbreaking rise of Viagra has firmly established as a example of pharmaceutical success, yet its position within the broader industry now triggers questions about long-term yields . Copycat versions are diminishing patent protection , leading to concerns that betting on companies significantly dependent to Viagra's previous standing could b